Dr. Mellati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 Madison St Ste 1270
Seattle, WA 98104Phone+1 206-796-3636Fax+1 334-714-7958
Education & Training
University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2017
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2012 - 2014
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2011 - 2012
Certifications & Licensure
WA State Medical License 2014 - 2027- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 11 citationsLow concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro.Andrew T. Templin, Mahnaz Mellati, Daniel T. Meier, Nathalie Esser, Meghan F. Hogan
Diabetologia. 2020-07-29 - 8 citationsLoss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice.Andrew T. Templin, Mahnaz Mellati, Raija Soininen, Meghan F. Hogan, Nathalie Esser
Protein Engineering, Design & Selection. 2019-12-13 - 18 citationsApoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.Andrew T. Templin, Tanya Samarasekera, Daniel T. Meier, Meghan F. Hogan, Mahnaz Mellati
Diabetes. 2017-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
